Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,234
datasets available to search
ShareScore release 0.9.0
Dataset results
2,234 results for “Paclitaxel”
TAK-228 and TAK-117 Followed by Cisplatin and Nab Paclitaxel for Metastatic Triple Negative Breast Cancer
ClinicalTrials.gov study NCT03193853. IPD Sharing: YES. Countries: 1. Publications: 1.
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
ClinicalTrials.gov study NCT01414608. IPD Sharing: Not stated. Countries: 5. Publications: 2.
Study of Weekly Paclitaxel With Ramucirumab in Participants With Advanced Gastric Adenocarcinomas
ClinicalTrials.gov study NCT01253525. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Atezolizumab Plus Tiragolumab in Combination With Paclitaxel and Cisplatin Compared With Paclitaxel and Cisplatin as First-Line Treatment in Participants With Unresectable Locally Advanced,
ClinicalTrials.gov study NCT04540211. IPD Sharing: YES. Countries: 5. Publications: 2.
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer
ClinicalTrials.gov study NCT00609791. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Dasatinib In Combination With Trastuzumab And Paclitaxel In First Line Treatment Of Her2-Positive MBC Patients
ClinicalTrials.gov study NCT01306942. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
ClinicalTrials.gov study NCT01989676. IPD Sharing: YES. Countries: 24. Publications: 3.
Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
ClinicalTrials.gov study NCT00329641. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Cetuximab, Carboplatin, and Paclitaxel Followed by Radiation Therapy, With or Without Cisplatin, in Treating Patients With Metastatic Head and Neck Cancer
ClinicalTrials.gov study NCT00301028. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer
ClinicalTrials.gov study NCT01091428. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Nab-Paclitaxel and Gemcitabine for Recurrent/Refractory Sarcoma
ClinicalTrials.gov study NCT02945800. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
ClinicalTrials.gov study NCT00262847. IPD Sharing: Not stated. Countries: 4. Publications: 9.
Cisplatin vs Paclitaxel for Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01982448. IPD Sharing: NO. Countries: 1. Publications: 2.
A Phase 1B Study of Canakinumab, Spartalizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer (PC) Patients
ClinicalTrials.gov study NCT04581343. IPD Sharing: NO. Countries: 1. Publications: 9.
A Double-blind Study of Paclitaxel in Combination With Reparixin or Placebo for Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT02370238. IPD Sharing: NO. Countries: 7. Publications: 2.
Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer
ClinicalTrials.gov study NCT02187991. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response
ClinicalTrials.gov study NCT00807573. IPD Sharing: Not stated. Countries: 1. Publications: 2.
QUILT-3.010: A Study of Gemcitabine and Nab-paclitaxel With or Without NPC-1C to Treat Patients With Pancreatic Cancer
ClinicalTrials.gov study NCT01834235. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer
ClinicalTrials.gov study NCT00057863. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)
ClinicalTrials.gov study NCT02301143. IPD Sharing: Not stated. Countries: 5. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.